Cancer Detectives: Finding the Cures S1E2 27 November 2025 on Channel 4

On Thursday 27 November 2025, Channel 4 broadcasts Cancer Detectives: Finding the Cures!
Season 1 Episode 2 Episode Summary
The upcoming episode of “Cancer Detectives: Finding the Cures” on Channel 4 promises to be an inspiring look at the fight against cancer. In this episode, viewers will meet trailblazing scientists who are dedicated to finding new treatments and cures for this challenging disease.
One of the key figures in this episode is neurosurgeon Richard Mair. He is working on a groundbreaking trial that aims to help patients suffering from deadly brain cancer. This trial is unique and may offer hope to those who have few options left. Richard’s determination and innovative approach highlight the ongoing battle against cancer and the commitment of medical professionals to improve patient outcomes.
As the episode unfolds, it will showcase the challenges and breakthroughs that come with cancer research. Richard Mair’s work exemplifies the dedication required to push the boundaries of science and medicine. This episode is sure to resonate with anyone interested in the advancements being made in cancer treatment and the stories of those affected by the disease.
Tune in to Channel 4 to see how Richard and his team are working to change lives and potentially save patients from the grips of brain cancer. This episode of “Cancer Detectives: Finding the Cures” is set to be both informative and moving, shedding light on the important work being done in the field of cancer research.
What Time is the Episode On?
The episode of Cancer Detectives: Finding the Cures will be broadcast on November 27 2025 on Channel 4 at 10:00 PM.
Is the Episode New?
The episode of Cancer Detectives: Finding the Cures is all new!
Cancer Detectives: Finding the Cures Cast & Stars
| Main Cast |
|---|
Episode Videos & Previews
Watch Cancer Detectives: Finding the Cures Online
| Watch the show online |
Cancer Detectives: Finding the Cures Series Information
| Professor Sarah Blagden's clinical trials feature Trevor, a retired Navy veteran whose skin cancer has spread, and 26-year-old Ella with a genetic condition that gives her a 90 percent chance of developing the disease. |
